152 related articles for article (PubMed ID: 19507803)
1. Two milligrams i.v. hydromorphone is efficacious for treating pain but is associated with oxygen desaturation.
Chang AK; Bijur PE; Napolitano A; Lupow J; Gallagher EJ
J Opioid Manag; 2009; 5(2):75-80. PubMed ID: 19507803
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trial comparing a patient-driven titration protocol of intravenous hydromorphone with traditional physician-driven management of emergency department patients with acute severe pain.
Chang AK; Bijur PE; Davitt M; Gallagher EJ
Ann Emerg Med; 2009 Oct; 54(4):561-567.e2. PubMed ID: 19560838
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety profile of a single dose of hydromorphone compared with morphine in older adults with acute, severe pain: a prospective, randomized, double-blind clinical trial.
Chang AK; Bijur PE; Baccelieri A; Gallagher EJ
Am J Geriatr Pharmacother; 2009 Feb; 7(1):1-10. PubMed ID: 19281935
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of rapid titration using 1mg doses of intravenous hydromorphone in emergency department patients with acute severe pain: the "1+1" protocol.
Chang AK; Bijur PE; Campbell CM; Murphy MK; Gallagher EJ
Ann Emerg Med; 2009 Aug; 54(2):221-5. PubMed ID: 18996618
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial comparing the safety and efficacy of a hydromorphone titration protocol to usual care in the management of adult emergency department patients with acute severe pain.
Chang AK; Bijur PE; Gallagher EJ
Ann Emerg Med; 2011 Oct; 58(4):352-9. PubMed ID: 21507527
[TBL] [Abstract][Full Text] [Related]
6. A multicenter, open-label, exploratory dose-ranging trial of intranasal hydromorphone for managing acute pain from traumatic injury.
Wermeling DP; Clinch T; Rudy AC; Dreitlein D; Suner S; Lacouture PG
J Pain; 2010 Jan; 11(1):24-31. PubMed ID: 19592310
[TBL] [Abstract][Full Text] [Related]
7. Randomized Controlled Trial of Intravenous Acetaminophen Versus Intravenous Hydromorphone for the Treatment of Acute Pain in the Emergency Department.
Barnaby DP; Chertoff AE; Restivo AJ; Campbell CM; Pearlman S; White D; Bijur PE; Gallagher EJ
Ann Emerg Med; 2019 Feb; 73(2):133-140. PubMed ID: 30119941
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of hydromorphone as an analgesic alternative to morphine in acute pain: a randomized clinical trial.
Chang AK; Bijur PE; Meyer RH; Kenny MK; Solorzano C; Gallagher EJ
Ann Emerg Med; 2006 Aug; 48(2):164-72. PubMed ID: 16857467
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
Hale M; Tudor IC; Khanna S; Thipphawong J
Clin Ther; 2007 May; 29(5):874-888. PubMed ID: 17697906
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of efficacy and safety of a single 2-mg intravenous dose of hydromorphone versus usual care in the management of acute pain.
Chang AK; Bijur PE; Lupow JB; John Gallagher E
Acad Emerg Med; 2013 Feb; 20(2):185-92. PubMed ID: 23406078
[TBL] [Abstract][Full Text] [Related]
11. Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain.
Nalamachu S; Ruck D; Nalamasu R; Fasbinder S; Bansal R
J Opioid Manag; 2013; 9(1):43-9. PubMed ID: 23709303
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Response in Emergency Department Patients Receiving Intravenous Opioids for Severe Pain.
Radcliff JA; Rafeq RM; Bowen JF; Pontiggia L; Sen S
Pharmacotherapy; 2017 Jul; 37(7):799-805. PubMed ID: 28500651
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
O'Connor AB; Zwemer FL; Hays DP; Feng C
Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
[TBL] [Abstract][Full Text] [Related]
14. Effective analgesia with low-dose ketamine and reduced dose hydromorphone in ED patients with severe pain.
Ahern TL; Herring AA; Stone MB; Frazee BW
Am J Emerg Med; 2013 May; 31(5):847-51. PubMed ID: 23602757
[TBL] [Abstract][Full Text] [Related]
15. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
[TBL] [Abstract][Full Text] [Related]
16. Intranasal hydromorphone for treatment of acute pain in children: A pilot study.
Tsze DS; Pan SS; DePeter KC; Wagh AM; Gordon SL; Dayan PS
Am J Emerg Med; 2019 Jun; 37(6):1128-1132. PubMed ID: 30902361
[TBL] [Abstract][Full Text] [Related]
17. Long-term safety, tolerability, and efficacy of OROS hydromorphone in patients with chronic pain.
Wallace M; Moulin DE; Rauck RL; Khanna S; Tudor IC; Skowronski R; Thipphawong J
J Opioid Manag; 2009; 5(2):97-105. PubMed ID: 19507806
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO-127).
Wallace M; Skowronski R; Khanna S; Tudor IC; Thipphawong J
Curr Med Res Opin; 2007 May; 23(5):981-9. PubMed ID: 17519065
[TBL] [Abstract][Full Text] [Related]
19. Acute pain control challenges with buprenorphine/naloxone therapy in a patient with compartment syndrome secondary to McArdle's disease: a case report and review.
McCormick Z; Chu SK; Chang-Chien GC; Joseph P
Pain Med; 2013 Aug; 14(8):1187-91. PubMed ID: 23647815
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of an Acute Pain Titration Protocol Driven by Patient Response to a Simple Query: Do You Want More Pain Medication?
Chang AK; Bijur PE; Holden L; Gallagher EJ
Ann Emerg Med; 2016 May; 67(5):565-72. PubMed ID: 26074387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
